Dank, M.; Mühl, D.; Herold, M.; Hornyák, L.; Szasz, A.M.; Herold, Z.
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? J. Clin. Med. 2022, 11, 4815.
https://doi.org/10.3390/jcm11164815
AMA Style
Dank M, Mühl D, Herold M, Hornyák L, Szasz AM, Herold Z.
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? Journal of Clinical Medicine. 2022; 11(16):4815.
https://doi.org/10.3390/jcm11164815
Chicago/Turabian Style
Dank, Magdolna, Dorottya Mühl, Magdolna Herold, Lilla Hornyák, Attila Marcell Szasz, and Zoltan Herold.
2022. "Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?" Journal of Clinical Medicine 11, no. 16: 4815.
https://doi.org/10.3390/jcm11164815
APA Style
Dank, M., Mühl, D., Herold, M., Hornyák, L., Szasz, A. M., & Herold, Z.
(2022). Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? Journal of Clinical Medicine, 11(16), 4815.
https://doi.org/10.3390/jcm11164815
